Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIAL Study

RCT (n=31) found that use of Dexcom G6 CGM system in young people with type 1 diabetes improves time in target (35.7% vs. 24.6%; p <0.001).and HbA1c levels (reduced by 0.76% [−8.5 mmol/mol]; p <0.001) compared with self-monitoring of blood glucose.


Diabetes Care